To find out the prevalence of Anxiety, Depressive symptoms and Substance use in persons with Schizophrenia.
Not Applicable
- Conditions
- Health Condition 1: F20- Schizophrenia
- Registration Number
- CTRI/2023/11/059495
- Lead Sponsor
- Government Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Diagnosis of Schizophrenia according to ICD-11.
2. Age group 18- 60 years.
3. Any gender.
4. Duration of Illness less than 5
Exclusion Criteria
1. Individuals with intellectual disability, uncooperative and violent patient.
2. Patient’s not giving consent.
3. Actively Suicidal patients
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To estimate the Prevalence of Anxiety, Depressive symptoms and Substance use in persons with Schizophrenia.Timepoint: Baseline
- Secondary Outcome Measures
Name Time Method To assess the frequency & severity of Anxiety, Depressive symptoms & Substance Use in persons with Schizophrenia.Timepoint: Baseline;To find correlation among Anxiety, Depressive symptoms & Substance Use with severity of Schizophrenia.Timepoint: Baseline